Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

ImmunoCellular Therapeutics Ltd Company Profile (NYSE:IMUC)

Consensus Ratings for ImmunoCellular Therapeutics Ltd (NYSE:IMUC) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for ImmunoCellular Therapeutics Ltd (NYSE:IMUC)
Show:
DateFirmActionRatingPrice TargetDetailsShare
12/12/2013MLV & Co DowngradeBuy -> Hold$1.25 -> $6.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 12/21/2012 forward)